Inj desmopressin acetate
Products billed under this code include Ddavp, Desmopressin Acetate.
Payment limit per 1 MCG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Ddavp, Desmopressin Acetate.
Payment limit per 1 MCG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Ddavp | Ferring Pharmaceuticals Inc. | 55566-2200-00 | 40 | $139.00 |
| Ddavp | Ferring Pharmaceuticals Inc. | 55566-2300-00 | 40 | $139.00 |
| Desmopressin Acetate | Sagent Pharmaceuticals | 25021-0460-01 | 40 | $139.00 |
| Desmopressin Acetate | Sagent Pharmaceuticals | 25021-0461-10 | 40 | $139.00 |
| Desmopressin Acetate | XGen Pharmaceuticals DJB, Inc. | 39822-6200-02 | 40 | $139.00 |
| Desmopressin Acetate | XGen Pharmaceuticals DJB, Inc. | 39822-6250-01 | 40 | $139.00 |
| Desmopressin Acetate | Dr. Reddy's Laboratories Inc. | 43598-0053-11 | 40 | $139.00 |
| Desmopressin Acetate | Dr. Reddy's Laboratories Inc. | 43598-0931-09 | 40 | $139.00 |
| Desmopressin Acetate | FreseniUS Kabi USA, LLC | 65219-0293-01 | 40 | $139.00 |
| Desmopressin Acetate | FreseniUS Kabi USA, LLC | 65219-0295-10 | 40 | $139.00 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Desmopressin Acetate | Nordic Pharma, Inc | 69918-0899-10 | 40 | $139.00 |
| Desmopressin Acetate | Nordic Pharma, Inc | 69918-0899-11 | 40 | $139.00 |
| Desmopressin Acetate | Nordic Pharma, Inc | 69918-0901-10 | 40 | $139.00 |
| Desmopressin Acetate | Nordic Pharma, Inc | 69918-0901-11 | 40 | $139.00 |
| Desmopressin Acetate | Nordic Pharma, Inc | 69918-0901-12 | 40 | $139.00 |
| Desmopressin Acetate | Sun Pharmaceutical Industries, Inc. | 70095-0026-02 | 40 | $139.00 |
| Desmopressin Acetate | Sun Pharmaceutical Industries, Inc. | 70095-0031-01 | 40 | $139.00 |
| Desmopressin Acetate | Athenex Pharmaceutical Division, LLC | 70860-0454-01 | 40 | $139.00 |
| Desmopressin Acetate | Athenex Pharmaceutical Division, LLC | 70860-0454-10 | 40 | $139.00 |
| Desmopressin Acetate | Avenacy Inc. | 83634-0451-01 | 40 | $139.00 |
| Desmopressin Acetate | Avenacy Inc. | 83634-0451-10 | 40 | $139.00 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $3.475 | −$0.087 | 1 MCG | Inj desmopressin acetate | v1, posted September 17, 2026 |
| 3Q26 | $3.562 | +$0.149 | 1 MCG | Inj desmopressin acetate | v1, posted September 15, 2026 |
| 2Q26 | $3.413 | −$0.001 | 1 MCG | Inj desmopressin acetate | v1, posted September 15, 2026 |
| 1Q26 | $3.414 | −$0.11 | 1 MCG | Inj desmopressin acetate | v1, posted September 15, 2026 |
| 4Q25 | $3.524 | −$0.37 | 1 MCG | Inj desmopressin acetate | v1, posted September 8, 2026 |
| 3Q25 | $3.894 | −$0.498 | 1 MCG | Inj desmopressin acetate | v1, posted March 10, 2026 |
| 2Q25 | $4.392 | −$0.48 | 1 MCG | Inj desmopressin acetate | v1, posted March 10, 2026 |
| 1Q25 | $4.872 | −$0.548 | 1 MCG | Inj desmopressin acetate | v1, posted December 19, 2025 |
| 4Q24 | $5.42 | −$0.143 | 1 MCG | Inj desmopressin acetate | v1, posted June 11, 2025 |
| 3Q24 | $5.563 | −$0.71 | 1 MCG | Inj desmopressin acetate | v1, posted June 11, 2025 |
| 2Q24 | $6.273 | −$0.055 | 1 MCG | Inj desmopressin acetate | v1, posted March 11, 2025 |
| 1Q24 | $6.328 | +$0.183 | 1 MCG | Inj desmopressin acetate | v1, posted December 19, 2024 |
| 4Q23 | $6.145 | −$1.126 | 1 MCG | Inj desmopressin acetate | v1, posted October 10, 2024 |
| 3Q23 | $7.271 | +$0.195 | 1 MCG | Inj desmopressin acetate | v1, posted June 5, 2024 |
| 2Q23 | $7.076 | −$0.257 | 1 MCG | Inj desmopressin acetate | v1, posted February 23, 2024 |
| 1Q23 | $7.333 | −$0.278 | 1 MCG | Inj desmopressin acetate | v1, posted December 6, 2023 |
| 4Q22 | $7.611 | −$0.095 | 1 MCG | Inj desmopressin acetate | v1, posted June 22, 2023 |
| 3Q22 | $7.706 | −$0.565 | 1 MCG | Inj desmopressin acetate | v1, posted June 9, 2023 |
| 2Q22 | $8.271 | −$1.016 | 1 MCG | Inj desmopressin acetate | v1, posted December 14, 2022 |
| 1Q22 | $9.287 | −$0.115 | 1 MCG | Inj desmopressin acetate | v1, posted June 8, 2022 |
| 4Q21 | $9.402 | −$0.455 | 1 MCG | Inj desmopressin acetate | v1, posted June 2, 2022 |
| 3Q21 | $9.857 | −$0.235 | 1 MCG | Inj desmopressin acetate | v1, posted June 2, 2022 |
| 2Q21 | $10.092 | −$0.48 | 1 MCG | Inj desmopressin acetate | v1, posted March 1, 2022 |
| 1Q21 | $10.572 | – | 1 MCG | Inj desmopressin acetate | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.